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Objectives: The aim of this mini review is to determine the relationship between
endometriosis and urinary tract symptoms and to investigate the consequences of
surgical treatment of mild to severe endometriosis, especially deep lesions, on the
vesico-sphincteral function (lower urinary tract function).
Materials and methods: We performed a literature review by searching the MEDLINE
database for articles published between 2000 and 2014, limiting the searches to the
words: urinary tract, vesico-sphincteral, dysfunction, endometriosis, symptoms, and
surgery.
Results: The incidence of vesico-sphincteral symptoms in endometriosis varies from 3.4
up to 15.4%. The frequency of such symptoms seems to be under estimated because
of a lack of specific questionnaire including urinary symptoms. Urodynamic evaluation
could help to detect unsuspected abnormalities. It seems that endometriosis surgery
(particularly deep infiltrating lesions) is a purveyor of de novo urinary dysfunction, with
an incidence varying from 6.8 up to 17.5%. Nerve sparing processes such as neuro-
navigators or neuro-stimulators seem to be promising techniques to avoid postoperative
urinary tract dysfunction.
Conclusion: A precise anamnesis and the use of specific validated questionnaires
(IPSS and BFLUTS) improve the screening of vesico-sphincteral symptoms in case of
endometriosis. No recommendation can be found in the literature about the place of
urodynamic evaluation. Most publications lack of proof and therefore do not allow making
recommendations about optimal treatment of endometriotic lesions to avoid urinary tract
disorders.
Keywords: endometriosis, surgery, bladder, sphincter, deep endometriosis, urinary tract
Introduction
Sampson gave the term “endometriosis” to a pathology primarily described in 1860 by Von
Rokitansky. This pathology is a benign disease with high prevalence in women of reproductive
age. Its etiology and pathogenesis are controversial but it is believed to involve multiple, genetic,
environmental, immunological, angiogenic, endocrine, and even embryonic processes (1, 2). It is
defined by the presence of endometrial and stromal glands out of the uterine cavity. It is estimated
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that 10–20%ofwomenof childbearing age are affected (3), causing
a variety of symptoms and diminishing their quality of life.
Vesico-sphincteral disorders such as voiding troubles are often
masked by other symptoms of endometriosis such as pelvic pain
(dysmenorrhea, dyspareunia, and chronic pelvic pain), menstrual
cycle disturbances, and infertility.
The authors aim through this manuscript to update implica-
tions of endometriosis in vesico-sphincteral disorders.
Background
Adenomyosis, previously called “internal endometriosis,” is dis-
tinguished from “external endometriosis,” actually simply called
endometriosis. Adenomyosis is defined as the invasion of the
myometrium by endometrial tissue (glands and stroma) (4).
Endometriosis is defined as all other locations of endometrial
tissue. Deep infiltrating endometriosis (DIE) is characterized by
an infiltration of more than 5mm of endometrial tissue into
retroperitoneal space. Locations of DIE include the uterine torus,
posterior fornix, uterosacral ligaments, rectum, vagina, and uri-
nary tract (4).
The distribution of endometriotic lesions, regardless to their
type (deep, superficial, or cyst-like), is heterogeneous, but the
disease is most often pelvic-located (fallopian tubes, broad liga-
ments, ovaries, bladder and urethra, pelvic peritoneum including
the Douglas’ pouch, utero-sacral ligaments, recto-vaginal sep-
tum, lower digestive system). Lesions are more likely situated
in the posterior wall and on the left side of the pelvis (4). Ten
percent of women with deep endometriosis show a gastroin-
testinal involvement. In those cases, involvement of the rec-
tum and the recto-sigmoid portion occurs in 70–93% of the
cases (4).
Involvement of the lower urinary tract is found in 0.2–2.5% of
the cases (3, 5). Bladder and ureteral lesions occurred in, respec-
tively, 25–85 and 15–75% of the cases, while renal and urethral
involvement remains rare (5%) (3, 6).
Extra-pelvic endometriosis locations such as the perineum,
laparotomy scars, trocar orifice, and spinal cord are reported in
medical literature (3).
Two hypotheses about the etiology of endometriosis are still up
to date and debated:
– The first one is the “implantation theory” (1), developed in 1927
by Sampson, suggesting that fragments of normal endometrium
flow back into the peritoneal cavity during retrogrademenstru-
ations, passing through the tuba, then graft on different sites.
Till nowadays, this hypothesis has found the largest approval.
As a matter of fact, desquamated endometrial cells were found
in the peritoneal cavity throughout the menstrual cycle. It
seems rational to assume that these cells can implant on the
peritoneum.
– The second one is the “metaplasia theory” (1), described in 1927
by Robert Meyer, which was based on suggestion that peri-
toneal tissue (Müllerian remnants) has a remainingmetaplastic
potential at adult age. This metaplastic phenomenon is more
likely to occur under certain circumstances, such as estrogen
influence and inflammatory phenomena.
Lower urinary tract endometriosis can be explained through
several physio-pathological theories (5, 7), among them:
i. The Sampson’s migratory theory, with implantation of
endometrial cells in the vesico-uterine pouch.
ii. The endometrial metaplasia of Müllerian remnants located in
the vesico-uterine pouch.
iii. The invasive theory corresponding to the extension of an
anterior adenomyotic nodule.
iv. The iatrogenic bladder endometriosis starting from a
cesarean scar.
It seems quite logical that a single theory can’t explain all
clinical situations, but they are complementary.
Physio-Pathological Explanations of
Endometriosis-Related Urinary Tract
Disorders
Pelvis innervation and voiding function are two complex systems
that associate an autonomous and a voluntary nervous system for
bladder emptying.
Bladder innervation is composed of:
– A voiding control center located in the brainstem and the sacral
segment of the spinal cord.
– The peripheral nervous system divided into:
i. The cholinergic pelvic innervation provided by the pelvic
nerves with a stimulating role on the bladder and other
smooth muscle cells.
ii. The adrenergic innervation provided by the hypogastric
plexus with both relaxing and contracting function of the
bladder and the ureter.
iii. The somatic pudendal innervation that commands the skele-
tal muscle cells (the external sphincter and the pelvic floor
muscles).
iv. The non-cholinergic non-adrenergic innervation (NANC sys-
tem) that has an afferent and efferent influence through
neurotransmitters and neuromodulators.
Vesico-sphincteral disorders observed in endometriosis (day-
time and night-time pollakiuria or urge incontinence, sponta-
neous and stress incontinence, urinary urgency, cystalgia, dysuria,
urinary retention, cramps or pain during or at the end of urina-
tion, decreased bladder sensitivity, macroscopic hematuria, lower
back pain: : :) imply an infiltration of the hypogastric plexus by
endometriosis lesions, in combination with inflammatory phe-
nomena. The involvement of the bladder, the ureter, or the urethra
by endometriotic lesions directly explains some of these urinary
symptoms (5, 8). According to Anaf et al., these events would be
related to an overexpression of neural growth factors (9).
Medullary invasion by endometriotic nodules is an exceptional
situation of the association between lower urinary tract disorders
and endometriosis. Only seven cases (of medullary invasion) have
been reported in literature with various neurological manifesta-
tions (hypoesthesia, weakness, failure of motor function), as well
as constipation and urinary retention (10).
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In case of pelvic endometriosis surgery, especially if involving
the Douglas’ pouch, the rectum, the recto-sigmoïd junction, and
the parameters, the postoperative bladder and sphincter distur-
bances are due to damages caused to the inferior hypogastric
plexus that passes the utero-sacral ligaments laterally close to the
rectum and the vaginal fornix (4, 9).
Bladder and Sphincter Symptoms in
Endometriosis
Preoperative Symptoms
The incidence of vesico-sphincteral symptoms in endometriosis
seems low compared to other gynecological and digestive man-
ifestations. It varies from 3.4 up to 15.4% (11) depending on
the method used to highlight those symptoms. Ballester et al.
(11) consider that this low incidence, especially in case of deep
endometriosis, can be explained by the preponderance of gyneco-
logical and digestive symptoms. They also estimate that question-
naires used to diagnose endometriosis do not specifically include
lower urinary symptoms items.
According to le Tohic et al. (5), in case of bladder endometriotic
involvement, the catamenial rhythm of manifestations is an abso-
lutely constant feature. Lower urinary symptoms were presented
by cystalgia, dysuria, pollakiuria or urge incontinence, andmacro-
scopic hematuria in, respectively, 58.3, 25, 16.6, and 12.5% of the
cases.
In a study about preoperative evaluation of women with deep
endometriosis, Boileau et al. reported an incidence of 65% of
painful voiding and 4% dysuria, while the incidence of both gyne-
cological and digestive symptoms was, respectively, 91 and 48%
(4). In another study performed by Lapasse et al. (8) concerning
12 patients with deep endometriosis of the posterior pelvic wall,
the anamnesis highlighted vesico-sphincteral symptoms among
50% of the patients (day-time and night-time pollakiuria, Urge
incontinence, Bladder voiding by thurst, lower back pain, dysuria,
full bladder cramps or pain, cramps or pain during or at end
of urination, stress incontinence, decreased bladder sensitivity)
(Table S1 in Supplementary Material).
In a comparative study between a group of patients carrying
deep endometriosis and a control group, Ballester et al. (11),
based on a validated questionnaire (IPSS: International Prostate
Symptom Score) (12), showed a significantly higher incidence of
voiding dysfunction in deep endometriosis group compared to
control group (Table 1). Moreover, revealed urinary symptoms
were dysuria, urge incontinence, spontaneous urinary inconti-
nence, stress urinary incontinence, and cystalgia (when the blad-
der is full) in, respectively, 14.3, 28.7, 7.1, 15, and 30% of the
cases.
Postoperative Symptoms
Endometriosis surgery, in particular the one concerning deep
infiltrating lesions with posterior involvement (such as recto-
vaginal septum, cervical fornix, Douglas’ pouch, rectum, rec-
tosigmoïd junction, and parameters), regardless of the operating
technique (laparoscopic or open surgery), is a purveyor of de
novo lower urinary (bladder and sphincter) dysfunction such as
retention or dysuria. These disorders can be transient or persist in
the longer term. Their incidence varies through studies from 6.8
to 17.5% (8). Vashisht et al. (13) reported that impaired bladder
emptying occurred de novo in 14% of patients operated for a stage
III or IV endometriosis according to the r-AFS classification of
endometriosis. Dubernard and Volpi (14, 15) reported an inci-
dence of de novo urinary dysfunction up to 17% of the cases after
colorectal endometriosis. In a more recent prospective study by
Daraï et al. (16), the authors evaluated the incidence of vesico-
sphincteral dysfunction after deep endometriosis surgery, using
two validated questionnaires (IPSS and BFLUTS: Bristol Female
LowerUrinary Tract Symptoms); they showed that 29%of patients
reported self catheterization for an average of 3months; dysuria
was observed in 29% of patients; urge incontinence in 11% of
cases; spontaneous and stress incontinence in, respectively, 3 and
14% of cases. Another study (4) showed de novo voiding pain
and dysuria were observed in, respectively, 6 and 18% of cases
after deep endometriosis surgery. Dousset et al. (17) consider that
the most common and specific complication following colorectal
resections as part of the management of deep endometriosis is
transient peripheral neurogenic bladder with an incidence of 16%.
Urodynamic Evaluation
Deep endometriosis surgery, involving the uterosacral ligaments,
the rectum, and recto-vaginal septum, induces (as described
above) de novo vesico-sphincteral disorders caused by per opera-
tive nerve damage of the pelvic plexus. To distinguish preexisting
disorders from those appeared de novo, some authors such as
Lapasse et al. (8) propose to systematically carry out a preoperative
urodynamic investigation in case of deep endometriosis (Table 2).
To our knowledge, no other study about urodynamic evaluation in
case of deep endometriosis has been published.
The urinary flow study may reveal a multiphasic curve
(related to urination with abdominal thrust), a decreased flow
TABLE 1 | Comparison of urinary symptoms using the IPSS
Questionnaire (12).
IPSS Endometriosis
group
Control
group
p
Mean (DS) 95% CI Mean (DS) 95% CI
Symptoms of
bladder filling
2.5 (3.1) 1.4–3.6 3.8 (3.7) 3.2–4.4 0.005
Symptoms of
voiding
1.6 (1.5) 1.1–2.1 3.1 (3.1) 2.6–3.6 0.002
Total score 5.2 (5.3) 3.3–7.1 8.9 (7.8) 7.7–10.1 0.002
TABLE 2 | Preoperative urodynamic evaluation (8).
Normal urodynamic 2 cases (16.7%)
Significant post voiding residual 3 cases (25%)
Mean closure pressure 87, 833.5 cm H2O
Urethral hypertonia 4 cases (30%)
Urethral instability 3 cases (25%)
Dysuria 3 cases (25%)
Hypersensitive bladder 2 cases (16.7%)
Sphincteral deficiency [closure pressure <110  age] 2 cases (16.7%)
Bladder hypoesthesia 1 case (8.8%)
Reduced bladder capacity 1 case (8.8%)
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(<150mL/s), and a significant post voiding residual (>10% of
the urinated volume). Cystometric evaluation may show a hyper
or hypo compliant bladder (hypo or hypersensitive bladder, flat
curve, the first voiding-needmay be delayed or absent), a detrusor
hypocontractility with an increase in voiding duration, and/or
a post-voiding residual. Urethral profilometry may be normal;
however, a decreased urethral closure pressure is possible (in case
of pudendal or vegetative nerve lesion) (18).
Additional Investigations
Imaging Techniques
The radiological assessment in case of pelvic endometriosis (espe-
cially deep endometriosis) is based on ultrasound and MRI. In
case of bladder or ureteral involvement, the trans-abdominal
and/or trans-vaginal ultrasound can highlight echogenic nodular
images at the vesico-uterine cul-de-sac infiltrating the detrusor.
Given the multifocal nature of endometriotic lesions, the MRI
remains the key investigation when viewing a hyper intense signal
on T1 and persistent on T1 sequences with fat suppression reflect-
ing the character of hemorrhagic lesions. For ureteral lesions,
the T2-weighted MRI images provide identical images to that of
intravenous urography cavities and bring the possibility to analyze
the ureteral wall (19, 20).
Endoscopic Investigations
In the field of pelvic endometriosis, laparoscopy remains the gold
standard. It allows the diagnosis (through macroscopic appear-
ance and biopsy) and the treatment of the disease.
In case of bladder endometriosis, cystoscopy allows to visualize
the lesions as blue submucosal bulging nodules. The interest of
precise localization of those lesions related to the ureteral meatus
is to evaluate the need of preoperative placement of an endo-
prothesis (cystotomy vs ureterolysis) (20).
Management
In most cases and regardless of the localization, the management
of deep endometriosis lesions is surgical. The definitive diagno-
sis of endometriosis is histological, although a bundle of clinic-
radiological findings guide toward the diagnosis (20). The surgical
approach (conventional open surgery vs laparoscopy) depends on
the team and surgeon’s expertise and skills. When comparing the
delta values of urinary symptoms and quality of life using IPSS
score, Ballester et al. (9) found no significant difference between
laparoscopy and conventional open surgery. For voiding symp-
toms, ∆IPSS was 3.3 for laparoscopy and 1.3 for open surgery (p:
0.17), while for storage symptoms ∆IPSS was 1.2 for laparoscopy
and 2.2 for open surgery (p: 0.16). Quality of life was comparable
in both surgical routes (p: 0.45).
Different postoperative vesico-sphincteral manifestations (as
mentioned above) as well as anatomical and physio-pathological
data emphasize the need to develop a pelvic nerve-sparing
surgery. Since the first publication of Possover et al. (21), sev-
eral authors (11) have confirmed the feasibility of this surgi-
cal procedure (nerve-sparing surgery) with encouraging results.
Indeed, Possover et al. (21) have developed the LANN technique,
a technique of laparoscopic neuro-navigation to identify pelvic
autonomic nerves. This reduces the incidence of postoperative
bladder and sphincter disorders to <1%. Another method with
encouraging results was proposed by the same team (22), by estab-
lishing a nerve stimulator on the hypogastric plexus to prevent
bladder atony.
Regarding bladder lesions, the treatment of choice is par-
tial cystectomy (full-thickness surgical excision of the bladder
endometriosis lesion and its surrounding bladder wall), per-
formed by classic laparoscopy or laparotomy (20, 23). Laparo-
scopic partial cystectomy offers the same results as laparo-
tomy with several advantages such as less bleeding, short-
ened operative time, shortened hospital stay, quicker return to
work, a major reduction in postoperative pain, and a major
decreased risk of postoperative morbidity. To avoid recurrences
and postoperative pain, the excision has to be as complete
as possible. Concomitant cystoscopy can be useful for bet-
ter defining the margins of the endometriotic lesion. Preven-
tive catheterization of the ureters may be advisable, especially
when the distance between the caudal border of the endometri-
otic lesion and the interureteric ridge is <2 cm (24). An accu-
rate preoperative workup (anamnesis, clinical examination, and
imaging information; cystoscopy) is essential for planning a
correct laparoscopic approach. It is essential to ascertain the
precise location of the vesical endometriotic nodule (the dis-
tance with the ureteral meatus and the lower endometriotic
margins) (24).
Cystoscopy approach is not recommended and several argu-
ments were against it. First, endometriotic bladder lesions develop
inwards and complete resection involves accepting the risk of
bladder perforation. Second, endometriosis being a disease of the
peritoneal cavity, a complete assessment of the cavity is needed
and cystoscopy does not allow this (20).
Ureteral lesions are treated by ureterolysis or resection/
anastomosis based on intraoperative findings. When endometri-
otic lesions sheath the ureter, surgical procedure requires the
placement of a stent before ureterolysis. Lateral involvement of the
ureter usually requires resection/anastomosis (uretero-ureteral or
uretero-vesical anastomosis) (20).
Robotic-assisted laparoscopy has the advantage of an improved
level of freedom of instrumentation that allows more precise dis-
sections, reduces nerve lesions (owing to 3D vision) and improves
suturing techniques. However, the longer set-up time and greater
expense limit its use for reference centers (24, 25).
Medical therapies for endometriosis may be used alone or as
a complement to surgery. Prescribing medical treatment only
implies certainty or at least a strong suspicion of the diagnosis. It is
based on the sensitivity of the endometriotic tissue to hormones.
The main treatments used are progestogens, local progestogens
such as IUDwith levonorgestrel, danazol, combined contraceptive
pills, and GnRH analogs. Treatments success varies depending
on the location of endometriosis lesions. Even when symptoms
improve, it will tend to relapse when stopping treatment with a
recurrence rate of 56% (24).
Aromatase inhibitors are approved adjuvants for the treatment
of estrogen receptor-positive breast cancer.Molecular studies have
revealed the presence of aromatase P450, the key enzyme in the
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biosynthesis of ovarian estradiol, inside the endometriotic tissue,
indicating local synthesis of estradiol. Thereby, AIs represent an
appealing medical option for the management of different aspects
of this enigmatic disease, especially pelvic pain and infertility.
Accordingly, this review aims to evaluate the potential role of AIs
in the treatment of endometriosis-associated symptoms, mainly
pain and infertility. Notably, several studies have demonstrated
that the combination of AIs with conventional therapy as oral con-
traceptive pills, progestins, or gonadotropin-releasing hormone
analogs can be used to control endometriosis-associated pain and
pain recurrence in premenopausal women, particularly those with
pain due to rectovaginal endometriosis refractory to othermedical
or surgical treatment. Some case reports have shown promising
results in the treatment of postmenopausal endometriosis as first-
line treatment, when surgery is contraindicated, or as second-line
treatment in the case of postoperative recurrence (26).
In case of de Novo urinary disorders after surgery (urinary
retention, dysuria, : : :), different drug treatments have been pro-
posed, such as cholinergics or prokinetics (cisapride and bétané-
chol), but their effectiveness has not been demonstrated yet.
To date, standard treatment of urinary retention after surgery
remains self-catheterization. Neuromodulation of the superior
hypogastric plexus (inhibiting internal sphincter contraction and
strengthening detrusor contraction) for treatment of refractory
atonic bladder seems promising but should be confirmed by
further studies. In terms of prevention, surgical nerve sparing
techniques have been developed in order to minimize intraop-
erative injury of pelvic nerve plexus and reduce postoperative
morbidity (18).
Conclusion
It appears that bladder and sphincter disorders exist among
patients with deep endometriosis regardless of its location, and
thus before any surgery. The absence of previous symptoms
couldn’t exclude endometriotic lesions. A precise anamnesis is
fundamental to detect symptoms. The use of specific validated
questionnaires, such as IPSS and BFLUTS, improve screening.
Although it seems obvious that the implementation of urody-
namic evaluation before surgery for deep endometriosis could
help to detect unsuspected abnormalities, no recommendations
can be found in recent literature. Localization of endometriosis
lesions, such as in the posterior recto-vaginal septum, in Dou-
glas’pouch, in the rectum and recto-sigmoïd junction, appears to
be associated with a higher incidence of bladder and sphincter
disorders. Surgery for deep endometriosis, in particular when
extensive tissue resection is needed, is also responsible for de
novo bladder and sphincter disorders. Processes such as the
neuro-navigator and the neuro-stimulator placed laparoscopically
seem promising techniques. That being said, most publications
lack of proof and therefore do not allow extrapolating conclu-
sions or making recommendations about optimal management of
deep pelvic endometriosis related and its implication in vesico-
sphinteral disorders.
Supplementary Material
The Supplementary Material for this article can be found online
at http://journal.frontiersin.org/article/10.3389/fsurg.2015.00023
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